MOTS-c is improving insulin sensitivity and metabolic flexibility
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
Somewhat disappointed I havent lost more than thatalso havent havent had loss of appetite either
If you answered yes to any of those questions, then dont worry youve come to the right place
Are there any human studies of unapproved peptides
Researchers have investigated AHK-Cu for its involvement in hair follicle biology, dermal papilla cell activity, tissue remodelling, cellular signalling pathways, and cosmetic-focused research models